These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 70642)

  • 21. Dopamine: a prolactin-inhibiting hormone.
    Ben-Jonathan N
    Endocr Rev; 1985; 6(4):564-89. PubMed ID: 2866952
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered growth hormone release in Huntington's chorea.
    Keogh HJ; Johnson RH; Nanda RN; Sulaiman WR
    J Neurol Neurosurg Psychiatry; 1976 Mar; 39(3):244-8. PubMed ID: 132511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicle stimulating hormone, thyrotrophin, human growth hormone and prolactin in hyperemesis gravidarum.
    Ylikorkala O; Kauppila A; Haapalahti J
    Br J Obstet Gynaecol; 1976 Jul; 83(7):529-33. PubMed ID: 821511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic parkinsonism in Huntington's chorea.
    Moss JH; Stewart DE
    Can J Psychiatry; 1986 Dec; 31(9):865-6. PubMed ID: 2948633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disturbance of hypothalamic-pituitary hormone secretion in familial chorea-acanthocytosis].
    Terao S; Sobue G; Takahashi M; Miura N; Mitsuma T; Takeda A; Sakakibara T
    No To Shinkei; 1995 Jan; 47(1):57-61. PubMed ID: 7669403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of dopamine and thyrotropin releasing hormone on the volume of nuclei of prolactin cells in rat adenohypophysis in vitro.
    Lewiński A
    Endokrinologie; 1977 Jul; 69(2):217-21. PubMed ID: 410638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.
    Carr D; Gomez-Pan A; Weightman DR; Roy VC; Hall R; Besser GM; Thorner MO; McNeilly AS; Schally AV; Kastin AJ; Coy DH
    Br Med J; 1975 Jul; 3(5975):67-9. PubMed ID: 806323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EEG in Huntington's chorea: a clinical and neuropathological study.
    Scott DF; Heathfield KW; Toone B; Margerison JH
    J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):97-102. PubMed ID: 4260288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay.
    Jarry H; Leonhardt S; Gorkow C; Wuttke W
    Exp Clin Endocrinol; 1994; 102(6):448-54. PubMed ID: 7890021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.
    Tolis G; Goldstein M; Friesen HG
    J Clin Invest; 1973 Apr; 52(4):783-8. PubMed ID: 4632690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
    Magalov ShI; Dadali EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1158-63. PubMed ID: 6452012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin secretion by metoclopramide in man.
    Judd SJ; Lazarus L; Smythe G
    J Clin Endocrinol Metab; 1976 Aug; 43(2):313-7. PubMed ID: 7571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.
    Saft C; Hoffmann R; Strassburger-Krogias K; Lücke T; Meves SH; Ellrichmann G; Krogias C
    J Neural Transm (Vienna); 2015 Jun; 122(6):825-33. PubMed ID: 25503829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The formation and regulation of the lactotrophic function of the hypophysis in the prenatal period of rat development. II. Dopamine inhibitory control of prolactin secretion].
    Mel'nikova VI; Proshliakova EV; Sapronova AIa; Blue-Pazo MT; Calas A; Ugriumov MV
    Ontogenez; 1997; 28(2):121-4. PubMed ID: 9173350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin deficiency in pseudohypoparathyroidism.
    Carlson HE; Brickman AS; Bottazzo GF
    N Engl J Med; 1977 Jan; 296(3):140-4. PubMed ID: 401530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.